Consistent with our results, a recent report using proteomics analysis across a panel of glioblastoma tumor xenografts overexpressing wtEGFR or EGFRvIII identified GBP1 as well as three other proteins (S100A10, major vault protein, and carbonic anhydrase III) to be highly expressed in EGFRvIII expressing xenograft tumors relative to wtEGFR xenograft tumors. This evidence concerns the gene S100A10 and neoplasm.